Approvals/TGA/PRADAXA dabigatran etexilate 110 mg (as dabigatran etexilate mesilate) capsule blister pack

Approved

STANDARD

PRADAXA dabigatran etexilate 110 mg (as dabigatran etexilate mesilate) capsule blister pack

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 5fc402a2b3f7eae7
Product Name: PRADAXA dabigatran etexilate 110 mg (as dabigatran etexilate mesilate) capsule blister pack
Artg Id: 138402
Artg Name: PRADAXA dabigatran etexilate 110 mg (as dabigatran etexilate mesilate) capsule blister pack
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 2008-11-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/8cfa9b9503c8b1fc03b3373c510e0951.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/94994834cb537ca260d5788cbc21cb36.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

5fc402a2b3f7eae7

Type

Standard